GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Total Assets : ₦30,268 Mil (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Total Assets?

GlaxoSmithKline Consumer Nigeria's Total Assets for the quarter that ended in Jun. 2023 was ₦30,268 Mil.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Total Assets Growth Rate was -46.90% per year. During the past 3 years, the average Total Assets Growth Rate was -11.60% per year. During the past 5 years, the average Total Assets Growth Rate was -1.90% per year. During the past 10 years, the average Total Assets Growth Rate was -6.30% per year.

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest 3-Year average Total Assets Growth Rate was 23.50%. The lowest was -23.70%. And the median was -2.05%.

Total Assets is connected with ROA %. GlaxoSmithKline Consumer Nigeria's annualized ROA % for the quarter that ended in Jun. 2023 was 2.47%. Total Assets is also linked to Revenue through Asset Turnover. GlaxoSmithKline Consumer Nigeria's Asset Turnover for the quarter that ended in Jun. 2023 was 0.13.

GlaxoSmithKline Consumer Nigeria Total Assets Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Total Assets Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

15,700.06

18,685.34

23,735.66

26,252.73

29,386.20

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial															26,492.00	26,535.26	28,685.57	29,386.20	30,268.02

GlaxoSmithKline Consumer Nigeria Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

GlaxoSmithKline Consumer Nigeria's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	9532.452	+	19853.752
	=	29,386

GlaxoSmithKline Consumer Nigeria's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	9214.442	+	21053.574
	=	30,268

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Total Assets Explanation

Total Assets is connected with ROA %.

GlaxoSmithKline Consumer Nigeria's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	738.204	/	( (29386.204	+	30268.016)	/ 2 )
	=	738.204	/	29827.11
	=	2.47 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

GlaxoSmithKline Consumer Nigeria's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	3731.801	/	( (29386.204	+	30268.016)	/ 2 )
=	3731.801	/	29827.11
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

GlaxoSmithKline Consumer Nigeria Total Assets Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines